Century Therapeutics IPSC SEC Filings

NASDAQ IPSC
$2.13 +0.05 (+2.15%)
As of: Sep 4, 2026 · 2:15 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Century Therapeutics, Inc. (IPSC) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index